Progression‐free survival (A) and overall survival (B) by treatment in the second analysis of the national POLA cohort. Abbreviations: OS, overall survival; PCV, procarbazine, lomustine, and vincristine; PFS, progression‐free survival; RT, radiotherapy; TMZ, temozolomide.